Author:
Mishra Neelima,Prajapati Surendra Kumar,Kaitholia Kamlesh,Bharti Ram Suresh,Srivastava Bina,Phookan Sobhan,Anvikar Anupkumar R.,Dev Vas,Sonal Gagan Singh,Dhariwal Akshay Chandra,White Nicholas J.,Valecha Neena
Abstract
ABSTRACTMalaria treatment in Southeast Asia is threatened with the emergence of artemisinin-resistantPlasmodium falciparum. Genome association studies have strongly linked a locus onP. falciparumchromosome 13 to artemisinin resistance, and recently, mutations in the kelch13 propeller region (Pfk-13) were strongly linked to resistance. To date, this information has not been shown in Indian samples.Pfk-13mutations were assessed in samples from efficacy studies of artemisinin combination treatments in India. Samples were PCR amplified and sequenced from codon 427 to 727. Out of 384 samples, nonsynonymous mutations in the propeller region were found in four patients from the northeastern states, but their presence did not correlate with ACT treatment failures. This is the first report ofPfk-13point mutations from India. Further phenotyping and genotyping studies are required to assess the status of artemisinin resistance in this region.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
72 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献